Büller, Harry R <br/><br/>
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.  [electronic resource] 

 -  Lancet (London, England)  Jan 2012 
 - 123-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(11)61505-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--administration & dosage<br/>Biotin--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Enoxaparin--administration & dosage<br/>Factor X--antagonists & inhibitors<br/>Female<br/>Humans<br/>Intention to Treat Analysis<br/>Male<br/>Middle Aged<br/>Oligosaccharides--administration & dosage<br/>Pulmonary Embolism--drug therapy<br/>Warfarin--administration & dosage